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Introduction
The acquired immunodeficiency syndrome (AIDS) is a recently recognized disease caused by the human immunodeficiency virus (HIV),' formerly termed T cell lymphotropic virus III (1) or lymphoadenopathy-associated virus (2) . The hallmark of AIDS is depressed T cell immunity (3) (4) (5) owing to an infection of the helper/inducer T cell subset by the HIV (1) . Among the immunological abnormalities reported in patients with AIDS are 1 . Abbreviations used in this paper: AET, 2-amino-ethylisothiouronium bromide; ARC, AIDS-related complex; BFU-E, burst-forming unit-erythroid; CFU-GEM, colony-forming unit-granulocyte, erythrocyte, macrophage, (megakaryocyte); CFU-GM, CFU-granulocyte-macrophage; CFU-MK, CFU-megakaryocyte; HIV, human immunodeficiency virus; IMDM, Iscove's modified Dulbecco's medium; MNC, mononuclear cells; PHA-LCM, phytohemagglutinin-leukocytconditioned medium; SRBC, sheep red blood cells; Tr, autologous T cells; T, T cell-depleted bone marrow cells. diminished numbers (6, 7) and functions (8) ofcirculating helper/ inducer T cells, reversals of the T4 to T8 ratios (7) , production of soluble suppressor factors (9, 10) , decreased expression of HLA-DR antigen on monocytes (1 1), and diminished production of interleukin 2 and other lymphokines (12, 13) .
In addition to the derangement of the immune system, peripheral blood cytopenia of one or more hematological cell types has been noted in -60% ofthe patients (14) (15) (16) , and also bone marrow changes such as increased cellularity and abnormalities in maturation of different hemopoietic lineages, as in myelodysplasia, have been observed (16) (17) (18) .
The mechanisms responsible for the derangement of hemopoiesis in AIDS patients are still unknown. Although cytopenias in AIDS are sometimes associated with Coombs' test positivity (15) or the presence of anti-platelet antibodies (16, 19) , the significance of these antibodies is not clear (4) and direct involvement of the hemopoietic progenitor cells might also be an important factor (4, 20) .
The development of in vitro clonal assays for multipotent and committed hemopoietic progenitors has enhanced our understanding of the regulation of hemopoiesis and also of the interactions between accessory cells (T lymphocytes and macrophages) and hemopoietic progenitors (21, 22) . Several studies support the notion that disturbances in the activation of regulation or in the expansion of T cell subsets may result in hemopoietic failure (23) . Furthermore, Leiderman et al. (20) found a reduction in the number ofbone marrow-derived granulocytemacrophage progenitors (colony-forming unit-granulocytemacrophage [CFU-GM]) in patients with AIDS and the production of a factor inhibitory to normal progenitor cells.
It was the aim ofthe present study to establish the incidence of the multipotent hemopoietic progenitor cells (CFU-granu- (25, 26) . Equal volumes of 2% AET-treated SRBC and marrow or peripheral blood MNC were mixed and incubated for 10 min at 370C. After centrifugation at 200 g for 5 min at room temperature, the pellet was incubated for 60 min at 4VC. Then, the nonrosetting, T cell-depleted cell fraction was separated from rosetting, T cell-enriched cell fraction by a second Ficoll-Hypaque gradient (1.077 g/ml) centrifugation.
T cell-depleted and T cell-enriched cell fractions were treated with 0.83% Tris-buffered ammonium chloride, pH 7.2, washed twice in RPMI 1640 medium, and resuspended in IMDM. The viability ofboth T celldepleted and T cell-enriched cell fractions, as determined by Trypan blue dye exclusion, was always > 90%.
Routinely, T cell-enriched blood cells were 85-98% OKT3 positive, whereas T cell-depleted bone marrow cells (T-) were 91-98% OKT3 negative. Unseparated bone marrow light-density cells from patients with AIDS contained a mean of 22% OKT3-positive cells (range, 8-56%), whereas in the normal controls the mean was 16% (range, 6-30%).
Depletion of adherent cells. Bone marrow light-density cells resuspended at a concentration of 2.5 X 106/ml in IMDM containing 5% human fresh-frozen plasma were incubated in plastic dishes (Greiner, Nurtingen, FRG) at 370C in a 5% CO2 atmosphere. After 60 min the non-adherent cells were transferred to new plastic dishes for a further 60-min-incubation step. Without further washings, the non-adherent cell suspensions were then plated in the colony assays at a concentration of 4% (vol/vol) to allow a direct comparison with the controls.
Monocyte depletion was checked with the MY-4 monoclonal antibody (27) . Whereas 4-8% of the cells in the original cell suspensions were reactive with this antibody, < 0.5% of non-adherent cells were positive.
In vitro assays. The assay for CFU-GEM and committed progenitor cells has been previously described (28, 29 (31); erythroid bursts (BFU-E); and granulocyte-macrophage colonies (CFU-GM) were all scored from the same plates. Mixed colonies (CFU-GEM) could contain megakaryocytes, but this element was not especially quantitated in this study. Several batches of PHA-LCM were used. These were always produced by peripheral blood MNC from the same individual and tested for comparable stimulating activity. When tested retrospectively in our assay system, PHA-LCM stimulated in vitro colony formation of BFU-E and CFU-GM in comparable numbers as 5% medium conditioned for 5 d by the cell line 5637 (32) or as 0.5 ,ug/ml recombinant human granulocyte-macrophage-colony-stimulating factor (33) (Behring-Werke AG, Marburg/Lahn, FRG), whereas higher numbers of CFU-GEM and CFU-Mk were regularly obtained with our preparations of PHA-LCM (unpublished observations). Similarly, a single donor was used for providing human plasma throughout the whole study. Since initial experiments did not demonstrate any difference between fresh and heat-inactivated human plasma on colony formation by AIDS-derived bone marrow cells, only fresh-frozen plasma was used in the present study. According to the experimental design, populations of bone marrow T cells in two patients and/or peripheral blood T cells in seven patients, obtained by SRBC resetting, were added back to cultures containing 1 X IO' light-density T+ and T-. In these co-culture experiments the ratio of T-to T cells was 1:1.
The expected number of CFU-GEM or committed progenitor cells per 1 X I0O T-was calculated by (34):
Expected CFJ-GEM = (CFU-GEM/105 bone marrow cells) X { 100/(100 -[percentTcellsinbonemarrowcells
In three experiments, T' from the peripheral blood were readded to T-at ratios of 1:5, 1:2, and 1:1, respectively, and then plated.
In three experiments, bone marrow cells from normal controls and from patients with AIDS were resuspended at a concentration of 2.5 X 106/ml in IMDM containing 5% human fresh-frozen plasma. Irradiation of the respective samples with 25 gray (Gy) was carried out at a dose rate of 0.67 Gy/min using a Co-60 source before co-culture with non-irradiated cells.
Immunological characterization. The monoclonal antibodies OKT3, OKT4 and OKT8 (Ortho Pharmaceutical, Raritan, NJ) were employed to estimate the percentages of T cells, T cell subsets, and non-T cells in the bone marrow and peripheral blood MNC before and after T cellcell depletion. The monoclonal antibody MY-4 (Coulter Diagnostics, Hialeah, FL) was employed to estimate the percentages of monocytes before and after adherent cell depletion.
The immunological characterization was performed according to Bross et al. (35) . Briefly, the cells were transferred on to poly-L-lysin (Sigma Chemie GmbH Munchen)-coated spots on glass slides. Statistical analysis. The Student's t test for paired data was used to test for significance of changes in the number of progenitor cells grown from unseparated bone marrow, T-, and after addition of T cells. The Student's t test for unpaired data was used to test for significant differences between hemopoietic progenitor cell growth from the patients and the control group. The linear correlation analysis was used to correlate the percentages ofinhibition due to T cell readdition and the T4 to T8 ratios.
Results
Baseline growth of hemopoietic progenitor cells. Initial experiments were carried out to determine the influence of cell concentration on in vitro colony formation of AIDS-derived bone marrow cells. As shown in Fig. 1, there is bone marrow T lymphocytes on hemopoietic progenitor cell growth, bone marrow cell suspensions from nine patients were depleted of T cells by resetting with AET-treated SRBC. By T cell depletion, the percentage of T cells could be reduced from 8-56% down to 2-9% OKT3-positive cells. Table II shows the observed and expected numbers of colonies grown per 1 X I0 T-. The expected growth was calculated as described above.
T cell depletion increased significantly (P < 0.05) the growth of CFU-GEM to 3.4±1.3 (mean±SEM). In 3 of the 10 experiments the observed CFU-GEM per 101 T-were over 3, 7, and 15 times the expected values. In one of these cases the number of mixed colonies actually fell within the normal range. In four of the experiments T cell depletion resulted in a slight increase of CFU-GEM growth, whereas in three experiments no enhancement of colony growth was observed.
The growth of BFU-E (19.9±8.7), CFU-Mk (5.6±2.2), and CFU-GM (42.8±13.2) per l0 T-was also significantly enhanced (P < 0.025, P < 0.01, and P < 0.025, respectively) as compared with baseline growth. It should be noted that in each patient, the increase in colony growth after T cell depletion was homogeneous with regard to the different classes ofhemopoietic progenitor cells assayed, i.e., in each patient a high increase of CFU-GEM was related to a high increase of committed progenitors and vice versa.
In five control experiments using normal bone marrow, after T cell depletion the observed growth (mean±SEM) for CFU-GEM (15±4, P > 0.05) was 99% of expected; BFU-E (1 17+42, Co-culture of T' and T-resulted in a significant decrease of growth for CFU-GEM (P < 0.01), BFU-E (P < 0.01), CFU-Mk (P < 0.01), and CFU-GM (P < 0.001) (Fig. 3) . The decrease of growth, as compared with T-, ranged from 18 to 85% (mean, 44%) for CFU-GEM; from 11 to 44%1 (mean, 28%), BFU-E; from 0 to 100% (mean, 38%), CFU-Mk; and from 2 to 45% (mean, 20%), CFU-GM.
In the two patients in whom 1 X 105 T cell-depleted target cells were co-cultured both with circulating or marrow T cells, the effect of T lymphocytes was similar. As shown in Table III , readdition of T cells resulted in a dose-dependent reduction of colony formation.
The inhibitory effect of T' might have been dependent on the OKT4 to OKT8 ratio. Therefore, the percentage inhibition of hemopoietic progenitor cell growth was correlated to the OKT4 to OKT8 ratio in the T cells (Fig. 4) . In two patients the inhibitory effect of both peripheral blood and bone marrow T cells was studied in parallel. This correlation was statistically significant for CFU-GEM (r = -0.937, P < 0.001), BFU-E (r = -0.690, P < 0.05), CFU-Mk (r = -0.972, P < 0.001), and CFU-GM (r = -0.702, P < 0.05). No correlation was found Table III between the percentage inhibition and the absolute number of OKT4-or OKT8-positive cells.
In five control experiments with normal marrow cells the T+ failed to induce any change ofgrowth (mean±SEM) for CFU-GEM (14±3, P > 0.05), BFU-E (1 14±41, P > 0.05), CFU-Mk (18±1.6, P > 0.05), and CFU-GM (93±18, P > 0.05).
To analyze the influence of adherent cells on colony formation, the adherent cells were depleted from the cell suspension before culture in four experiments. Excluding enrichment of progenitor cells by the experimental design, no'change in colony formation (mean±SEM) was observed (CFU-GEM, 0.7±0.4 vs. 0.3±0.3; BFU-E, 20±12 vs. 16±4; CFU-Mk, 0.7±0.7 vs. 0±0; CFU-GM, 20±4 vs. 18±4), similar to the findings in normal persons (unpublished observation).
To further investigate the cause of decreased colony formation in patients infected with HIV, co-culture ofbone marrow cells from patients and from normal controls were performed. In two experiments with unirradiated cells, the number of colonies detected was consistent with the arithmetic sum of normal and AIDS-derived colonies (Table IV) (20), but also of the other committed progenitors, CFU-Mk and BFU-E, as well as of the multipotent CFU-GEM (28) . A significant decrease in the incidence of all four types of progenitor cells was found in the patients studied, which by itself could explain the peripheral blood cytopenia similar to the findings in the myelodysplastic syndromes (36) and in aplastic anemia (37) . The lack of a good correlation between the number of hemopoietic progenitor cells and the peripheral blood counts is a further indication that the hemopoietic system is capable to compensate for the deficiency of early hemopoietic progenitor cells under "normal" conditions, as previously shown in patients who have undergone highly aggressive chemotherapy (38) or allogeneic bone marrow transplantation (39) . After cytostatic therapy for Kaposi's sarcoma or the use of folic acid antagonists in the treatment ofopportunistic infections, patients with AIDS, however, develop prolonged cytopenia that might be due to the stress exerted on a defective progenitor cell system.
The estimation ofthe incidence ofthe progenitor cells in an aspirate from the posterior iliac crest only provides data on a limited volume of bone marrow at the site of aspiration, but does not allow to quantitate the total number of the progenitor cells in the body. Contamination with peripheral blood and selective loss of progenitor cells during the cell separation procedures might further lead to unpredictable variability in the number of marrow progenitors, but to some extent the variability was controlled by limiting the volume of the bone marrow aspirate (29) and by the absence ofgross abnormalities in cellularity ofthe samples. Although the numbers of light-density MNC per milliliter aspirate were somewhat lower in the samples taken from the patients, this difference cannot account for the reduction in the in vitro colony formation, especially since there was no correlation between the number of colonies and the number of low-density cells per unit volume. However, the unresolved problem remains in that we cannot extend our data on the total volume of the hemopoietic tissue of patients with AIDS.
Since different mechanisms might lead to a reduction of in vitro growth of the hemopoietic progenitor cells, for instance stem-cell destruction, inhibition of colony growth by T cells or monocytes, or an imbalance between the T cell-helper and T cell-suppressor lymphocytes, different experimental approaches were used to study the extent to which colony growth was influenced by these mechanisms.
T cell depletion resulted in a significant increase in colony growth not due to selective enrichment, which argues in favor of an inhibition by T cells (37) . Normally, no change in colony growth is observed after T cell depletion, which has previously been described (34) and also found in our control experiments. However, the colony growth reached normal values in only a minority of experiments. Explanations for this could be either incomplete T cell depletion leaving sufficient numbers of inhibitory T cells in culture, or the presence of still other inhibitory, but unidentified cells in the cell suspension. However, adherent cells can be largely excluded as a result ofour experiments. Furthermore, the inhibitory effect is probably not due to the production ofgamma-interferon within the 14-d culture, as has been discussed for aplastic anemia (40), since T lymphocytes from patients with AIDS cannot produce this type of interferon (13) .
Addition of T+ to T-led to a decrease in colony growth, again the degree of which was dependent on the number of T cells added. Since growth decrease was in addition inversely correlated to the T4 to T8 ratio, the balance between these two T cell subsets seems to have a pronounced effect on in vitro and probably in vivo growth ofbone marrow hemopoietic progenitor cells (41). The disparity between the increase in colony formation after T cell depletion, and the failure to inhibit normal progenitor cells by AIDS-derived bone marrow cells or to stimulate AIDSderived progenitor cells by normal bone marrow cells in the Gy. * Significantly different from 5 (P < 0.025) and 6 (P < 0.05). 6 Significantly different from 5
(P <0.001) and 6 (P < 0.01).
allogeneic co-culture experiments might be due to genetic restriction of the suppressive effect of the T cells (42) . Since HIV has been shown to infect many different cell types (43) , it might well be that hemopoietic progenitor cells are similarly affected, which leads to a reduction in their total number. This would explain the lack of complete restoration of colony growth after the depletion of T cells. However, direct proof for it, with demonstration of virus sequences in stem cells or their progeny, is still lacking and will require further studies using enriched stem-cell populations.
In conclusion, our experiments strongly support the involvement ofthe bone marrow-derived hemopoietic progenitor cell compartments in AIDS, which results is myelodysplastic changes and cytopenia, and are probably being caused by direct stem-cell depletion and T cell imbalance. First experiments indicate similar defects in the hemopoietic progenitor cell compartments of the peripheral blood in patients with AIDS.
